-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on CVS Health, Raises Price Target to $108

Benzinga·06/01/2026 14:10:22
Listen to the news
Truist Securities analyst David Macdonald maintains CVS Health (NYSE:CVS) with a Buy and raises the price target from $102 to $108.